CALIX, INC 8-K

What Happened Calix, Inc. (CALX) announced on April 21, 2026, that its Board amended the company’s existing stock repurchase program to authorize the repurchase of up to an additional $100.0 million of common stock, bringing the program’s total authorization to $525.0 million. The filing notes that as of March 28, 2026, the remaining authorized balance under the program was $63.4 million.

Key Details

• Board action date: April 21, 2026.
• Additional authorization: $100.0 million.
• New total authorization under the program: $525.0 million.
• Remaining authorized balance before amendment (as of March 28, 2026): $63.4 million.
• Repurchases may be made from time to time via open-market purchases, privately negotiated transactions, or other methods in accordance with SEC rules; the program does not obligate the company to buy any specific amount and can be suspended or discontinued.

Why It Matters A larger repurchase authorization gives Calix flexibility to buy back shares as part of its capital allocation strategy. Share repurchase programs can reduce outstanding share count and are one way management can return capital to shareholders or offset dilution from equity awards. The filing is a factual update on authorization and mechanics; actual repurchases will depend on market conditions and the company’s discretion.